WHO世界卫生组织：2025年全球疫苗安全咨询委员会第48次会议报告（英文版）

Menfive® (Menengococcal conjugate) vaccine safety At its virtual meeting, the Global Advisory Committee on Vaccine Safety (GACVS) reviewed data on the safety of MenFive®, a Neisseria meningitidis conjugate vaccine (A, C, W, X, Y). The data were from the first use of MenFive® in outbreak response campaigns in Niger and Nigeria in 2024. The campaigns comprised 3-pronged vaccine safety surveillance, including strengthened routine pharmacovigilance, cohort event monitoring (CEM) and sentinel surv